Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1521-1530 of 1757 for cancer

Edit search filters
  1. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota

    Rochester, MN

  2. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients

    Rochester, MN

  3. A Registry for Data and Biospecimen of Cancer and Autoimmune Diseases

    Rochester, MN

  4. A Study To Evaluate Regulation Of The Metabolism Of T-Cells By The Tumor Microenvironment In Ovarian Cancer Metastasis

    Scottsdale/Phoenix, AZ

  5. A Study To Evaluate Fractionated Radiation Therapy Utilizing GRID Therapy For Locally-advanced Bulky Tumors

    Jacksonville, FL, Rochester, MN

  6. Two Cancers, One Gene. Why Some People In Families Develop Melanoma Or Pancreas Cancer, While Still Others Never Develop Cancer (TCOG)

    Rochester, MN

  7. Collecting Blood And Stool Samples To Detect Colorectal Cancer Or Advanced Neoplasia In Lynch Syndrome Patients, CORAL Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Evaluating Markers Which Might Be A Predictor Of Pancreatic Cancer Or Precancer By Analyzing The Secretions (Fluid) From A Pancreatic Cyst

    Rochester, MN

  9. Cutaneous Tissue Using Ex Vivo Fluorescence Confocal Microscopy

    Rochester, MN

  10. Primary Tumor Research And Outcome Network (PTRON) Registry

    Rochester, MN

.

Mayo Clinic Footer